Tolvaptan 15 MG tablet UD 10S
Ended Awarded
- Contract number
- SPE2DR26FQN9J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,218
Award facts
- Contract value 100% obligated
- $12,218.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Tolvaptan 15 mg tablets in unit-dose packaging (10 count). This is a firm fixed-price delivery order with a ceiling value of $12,218.27 and an ultimate completion date of October 31, 2025. The contract represents a non-set-aside, competitively awarded procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 million prime contract vehicle that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supply support to federal customers including the Defense Health Agency and U.S. Coast Guard. The company's substantial IDC with DLA Troop Support Medical enables it to supply a broad range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare systems worldwide. The current delivery order for Tolvaptan, a medication used in the treatment of hyponatremia, exemplifies the company's role in fulfilling specialized pharmaceutical procurement requirements for the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQN9J?
SPE2DR26FQN9J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26FQN9J worth?
The government has obligated $12,218 on SPE2DR26FQN9J.
Is contract SPE2DR26FQN9J an order under another contract?
Yes. SPE2DR26FQN9J is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQN9J competed?
The extent of competition for SPE2DR26FQN9J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award